• Description
  • Additional information

Basic Info.

Semaglutide is a GLP-1 receptor agonist (incretin mimetic) used to treat type 2 diabetes and obesity. It stimulates insulin release, suppresses glucagon secretion, slows gastric emptying, and reduces appetite

Administered once weekly via subcutaneous injection, it helps lower blood sugar and promote weight loss


Send a Message

We'd love to hear from you if you have any questions!

Categories

Go Back Top